Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study - (:unkn) unknown (CIG MEDIA GROUP, LP, 2021)
Keywords: relapsed and refractory; Hodgkin lymphoma; brentuximab vedotin; autologous stem cell transplantation; consolidation